NeoGenomics (NASDAQ:NEO) announces the (undisclosed) pricing of a secondary offering of ~10.8M shares of common stock by current shareholder GE Medical Systems Information Technologies. The company will receive no proceeds from the sales.
Shares are down 4% premarket.
Previously: NeoGenomics launches stock offering (Dec. 11)
Subscribe for full text news in your inbox